Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Gene detection of therapeutic drugs for chronic cardiovascular and cerebrovascular diseases
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hypertension,Essential
1 trial -
Generic cetrorelix acetate
NORTHWEST BIOTHERAPEUTICS INC
Infertility
1 trial -
Genetic testing for 4 MODY genes (GCK, HNF1A, HNF4A, HNF1B)
United Therapeutics Europe Ltd
Maturity-onset Diabetes of the Young
1 trial -
Genotype detected through GenSeizer high-throughput gene capture technology
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Non - Tuberculosis Mycobacteria Lung Disease
1 trial -
Ginkgo Biloba Extract
The First People's Hospital of Lianyungang
Acute Ischemic Stroke
1 trial -
Glimepiride
Takeda
Type 2 Diabetes
1 trial -
Goal2Quit + NRT Sampling
BRIGHT MINDS BIOSCIENCES INC.
Cigarette Smoking
1 trial -
Goji berry
United Therapeutics Europe Ltd
Age-Related Macular Degeneration
1 trial -
Grain-Fed Beef Hamburger
United Therapeutics Europe Ltd
Inflammatory Response
1 trial -
Green Tea Extract
United Therapeutics Europe Ltd
Dysbiosis
1 trial -
Guben Kechuan Granules group
Universal Integrated
Chronic Obstructive Pulmonary Disease (COPD)
1 trial -
Guselkumab
BRIGHT MINDS BIOSCIENCES INC.
Psoriasis Vulgaris
1 trial -
HCQ/CQ and CAB combined treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Resistance, Disease
1 trial -
HCV+PWID
BRIGHT MINDS BIOSCIENCES INC.
HIV Infection
1 trial -
HLA-B*5801 test
BRIGHT MINDS BIOSCIENCES INC.
Stevens-Johnson Syndrome
1 trial -
Heparin Sodium
The First People's Hospital of Lianyungang
Cerebral Aneurysm
1 trial -
Hetrombopag
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hematological Disease
1 trial -
High Dose GGQL Decoction
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Diabetes Mellitus, Type 2
1 trial -
High Dose Vitamin D
Atrium Therapeutics
Breast
1 trial -
High Fiber Diet Intervention
Universal Integrated
Dietary Fiber
1 trial -
High Hyaluronic Acid concentrations (0.5 mg/ml)
NORTHWEST BIOTHERAPEUTICS INC
Infertility
1 trial -
High-amylose maize starch+acetate/butyrate
United Therapeutics Europe Ltd
Aerobic Endurance
1 trial -
Hippocampal avoidance WBRT
Hospital Authority, Hong Kong
Metastatic Malignant Neoplasm to Brain
1 trial -
Home based food
Universal Integrated
Malnutrition, Child
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources